期刊
AMERICAN JOURNAL OF PATHOLOGY
卷 177, 期 1, 页码 21-28出版社
ELSEVIER SCIENCE INC
DOI: 10.2353/ajpath.2010.090999
关键词
-
类别
资金
- National Institute of Health [HL28737, HL31963, HL52285, HL77297, HL91775]
DNA methylation, a key mechanism of repressing gene expression, is of particular relevance in controlling development and cell differentiation. We analyzed the extent and regulation of DNA methylation of the a-smooth muscle actin (alpha-SMA) gene to elucidate its potential role in myofibroblast differentiation. These experiments revealed the presence of three CpG islands that were methylated at different levels in fibroblasts, myofibroblasts, and alveolar epithelial type H cells. Coordinately, these cells expressed low, high, or no a-SMA, respectively. In addition, inhibition of DNA methyltransferase activity or knock down of DNA methyltransferase using specific small interfering RNA caused significant induction of a-SMA in fibroblasts. In contrast, induced overexpression of DNA methyltransferase suppressed a-SMA gene expression. Transforming growth factor 13 induced myofibroblast differentiation was enhanced or suppressed by knockdown or overexpression of DNA methyltransferase, respectively. Finally, in vitro DNA methylation of the a-SMA promoter suppressed its activity. These findings suggest that DNA methylation mediated by DNA methyltransferase is an important mechanism regulating the a-SMA gene expression during myofibroblast differentiation. (Am J Pathol 2010, 177.21-28; DOI: 10.2353/ajpath.2010.090999)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据